Gyros AB Quality Management System Receives ISO 9001:2008 Certification
News Dec 18, 2012
Gyros AB has announced that its quality management system has received ISO 9001:2008 certification.
The certification offers further reassurance to customers using the Gyros nanoliter-scale immunoassay platform that the products and services they receive are of a consistently high standard.
The Gyros platform is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands.
The quality management system was ISO 9001:2008 certified by Svensk Certifiering Norden.
Erik Walldén, CEO at Gyros, commented: “At Gyros we have developed our Quality Management System over many years in order to establish well-functioning operating procedures for all parts of the company. Becoming ISO 9001 registered enables customers to feel even more confident in our products and services, as this is a confirmation that we follow internationally accepted standards for quality management.”
Mechanism Behind Inflammatory Response to Cytoplasmic DNA IdentifiedNews
A team led by LMU‘s Veit Hornung has elucidated the mechanism by which human cells induce inflammation upon detection of cytoplasmic DNA. Notably, the signal network involved differs from that used in the same context in mice.READ MORE
Pathway in Neurons may Contribute to Neurodegenerative DiseaseNews
Pathway has received attention as potential drug target.READ MORE
Will we be able to use zinc oxide nanoparticles as fertilizers?News
Nanoparticle fertilisers do not pose a toxicity risk for food crops.READ MORE